There is some good evidence for this. This study below, from our Science library at this link, was a metanalysis of clinical trials that contained both blinded and non-blinded phases (all kinds of trials). They found that treatment-related self-reported improvements were greatly exaggerated in the non-blinded arms, when compared to the blinded arms. But there was no significant effect of blinding on observer-rated outcomes or objectively measurable outcomes.I think there is a simple sense in which the placebo effect for healing of a broken bone is small and the placebo effect for anything where the ascertainment of outcome is subjective, as for pain, is likely to be larger. ME is bound to fall more in the second category at least in the wider context of a spurious positive result that gets bundled under placebo effect.
** Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies.
Hróbjartsson A, Emanuelsson F, Skou Thomsen AS, Hilden J, Brorson S.
International journal of epidemiology. 2014 May 30;43(4):1272-83.
link to article
This study asks the question: "How much of an effect does blinding have on the outcomes of a clinical trial"? The researchers selected all clinical trials they could find that comprised two phases: one where participants were fully aware of what treatment they were getting, and the other where they were fully blinded. The authors found that participants' own ratings of their health/symptoms were powerfully affected by their knowledge of their treatment allocation. Treatment effects were much bigger when participants knew which treatment group they were in. However, objective measures, or ratings of health/symptoms made by a (blinded) observer were not affected in this way. This study shows that when participants have a strong expectation that a treatment will work, their perceptions of its effectiveness are massively inflated; consequently, trials that cannot be blinded (e.g, psychotherapy trials) should avoid outcomes that rely entirely on patients' own self reports.
This study below
Thanks @Woolie. That study is of relevance to my expert testimony to UK NICE. I could have made use of it I guess, although I sort of like the a priori approach to this. That is to say unblinded studies with subjective outcomes are by definition unreliable in the context of human nature. Nevertheless, having formal demonstration is useful to back up arguments if challenged.
I do find this interesting...placebo effect for anything where the ascertainment of outcome is subjective, as for pain, is likely to be larger
I hope you won't be banging your head against a brick wall of people who have decided ME is subjective and that talk of objectivity is irrelevant, or possibly even worse,who accept objective talk for tactical reasons only.
I have pointed out in my testimony, and can reiterate it, that objective endpoints are not in themselves best used as primary endpoints, since subjective symptoms are what actually matter, but as objective corroborators of the subjective outcomes. I have given an example of how that can be done and ha not been done in ME trials.
That worries me a bit. To me and my wife one of the most crucial measures of her recovery would be to be able to walk 8~10 miles across Dartmoor, or the South Downs, or the Lake District, etc, each day, as she once could. Very objective and very valid surely.I have pointed out in my testimony, and can reiterate it, that objective endpoints are not in themselves best used as primary endpoints, since subjective symptoms are what actually matter, but as objective corroborators of the subjective outcomes. I have given an example of how that can be done and ha not been done in ME trials.
That worries me a bit. To me and my wife one of the most crucial measures of her recovery would be to be able to walk 8~10 miles across Dartmoor, or the South Downs, or the Lake District, etc, each day, as she once could. Very objective and very valid surely.
So long as those you need to convince are indeed convinced by this very fine-lined distinction, then hopefully OK. I'm finding it hard to see how being able to walk is itself a subjective outcome.To be 'able to walk' I would regard as a subjective outcome. To have actually walked would be the objective corroboration.
I'm finding it hard to see how being able to walk is itself a subjective outcome.
That worries me a bit. To me and my wife one of the most crucial measures of her recovery would be to be able to walk 8~10 miles across Dartmoor, or the South Downs, or the Lake District, etc, each day, as she once could. Very objective and very valid surely.
Yes, but not enough on its own. If she then reported that she had to spend the rest of the week in bed, it wouldn't exactly be considered a success.
Being 'able to walk' is a a potential capacity that you judge and report - presumably self-report. Things like Chalder fatigue score include judged abilities like this. I probably was not that clear originally. Subjective outcomes are not only symptoms like pain, they are often things reported rather than measured. Of course there are further layers to subjectivity if there is an effect of motivation on actual execution of the walking, which is why we can expect a 6 minute walking time to be influenced by unblinding to test/control a bit. But a Fitbit that shows regular long periods of walking would be pretty objective evidence that the report reflected real improvement.
What is now clear to me is that I was insufficiently precise in my original post #650, and so things have veered away from what I was trying to get at with my original statement. So to step back and correct that, am repeating it here, but rephrased to avoid the ambiguity I inadvertently introduced ...I have pointed out in my testimony, and can reiterate it, that objective endpoints are not in themselves best used as primary endpoints, since subjective symptoms are what actually matter, but as objective corroborators of the subjective outcomes. I have given an example of how that can be done and ha not been done in ME trials.
To be fair, it does take years to acquire object permanence.Good point and one of the problems is that people do not see us when we are in rest-recovery or relapse.
Agreed my terminology was ambiguous. I was meaning it in the other well accepted sense - actually able to walk albeit only proven once successfully undertaken; not a preemptive perception. I didn't realise the ambiguity when I wrote it, hence my correction in earlier post.Being 'able to walk' is a a potential capacity that you judge and report
To be fair, it does take years to acquire object permanence.
It's a tough requirement, perhaps, but I really would like research into my disease to take into account object permanence. I guess it's just too darn much to ask of some people, but I will keep on insisting for that requirement until it is actually taken into account. One day, perhaps.